COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Income Growth Analysis including revenue, gross profit, operating profit, net profit, EPS, and other financial metrics. Compare income growth against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.

Revenue Growth

9.07%

Increased from previous period

Revenue growth exceeding 1.5x Healthcare median of 0.00%. Joel Greenblatt would investigate if growth quality matches quantity.

Cost of Revenue Growth

8.27%

Increased from previous period

Cost growth of 8.27% versus flat Healthcare costs. Walter Schloss would verify cost control.

Gross Profit Growth

12.51%

Increased from previous period

Growth of 12.51% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

3.16%

Increased from previous period

Margin change of 3.16% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Selling & Marketing Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Other Expenses Growth

25.99%

Increased from previous period

Other expenses change of 25.99% versus flat Healthcare costs. Walter Schloss would verify efficiency.

Operating Expenses Growth

8.87%

Increased from previous period

Operating expenses growth exceeding 1.5x Healthcare median of 4.24%. Jim Chanos would check for waste.

Total Costs & Expenses Growth

8.37%

Increased from previous period

Total costs growth exceeding 1.5x Healthcare median of 3.21%. Jim Chanos would check for waste.

Interest Expense Growth

No Data

No Data available this quarter, please select a different quarter.

Depreciation & Amortization Growth

11.18%

Increased from previous period

D&A growth exceeding 1.5x Healthcare median of 0.53%. Jim Chanos would check for overinvestment.

EBITDA Growth

21.31%

Increased from previous period

EBITDA change of 21.31% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

11.22%

Increased from previous period

Margin change of 11.22% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

26.60%

Increased from previous period

Income change of 26.60% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

16.07%

Increased from previous period

Margin change of 16.07% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

-1.33%

Increased from previous period

Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Pre-Tax Income Growth

24.06%

Increased from previous period

Income change of 24.06% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

13.74%

Increased from previous period

Margin change of 13.74% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

17.04%

Increased from previous period

Tax expense change of 17.04% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

30.23%

Increased from previous period

Income change of 30.23% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

19.40%

Increased from previous period

Margin change of 19.40% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

30.16%

Increased from previous period

EPS change of 30.16% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

30.16%

Increased from previous period

Diluted EPS change of 30.16% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

-0.00%

Decreased from previous period

Share count reduction while Healthcare median is 0.00%. Seth Klarman would investigate strategy.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric:

3349.T Income Growth Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Revenue Growth

9.07%

Increased from previous period

Revenue growth exceeding 1.5x Healthcare median of 0.00%. Joel Greenblatt would investigate if growth quality matches quantity.

Cost of Revenue Growth

8.27%

Increased from previous period

Cost growth of 8.27% versus flat Healthcare costs. Walter Schloss would verify cost control.

Gross Profit Growth

12.51%

Increased from previous period

Growth of 12.51% versus flat Healthcare gross profit. Walter Schloss would verify quality.

Gross Margin Ratio Growth

3.16%

Increased from previous period

Margin change of 3.16% versus flat Healthcare margins. Walter Schloss would verify quality.

R&D Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

G&A Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Selling & Marketing Expenses Growth

No Data

No Data available this quarter, please select a different quarter.

Other Expenses Growth

25.99%

Increased from previous period

Other expenses change of 25.99% versus flat Healthcare costs. Walter Schloss would verify efficiency.

Operating Expenses Growth

8.87%

Increased from previous period

Operating expenses growth exceeding 1.5x Healthcare median of 4.24%. Jim Chanos would check for waste.

Total Costs & Expenses Growth

8.37%

Increased from previous period

Total costs growth exceeding 1.5x Healthcare median of 3.21%. Jim Chanos would check for waste.

Interest Expense Growth

No Data

No Data available this quarter, please select a different quarter.

Depreciation & Amortization Growth

11.18%

Increased from previous period

D&A growth exceeding 1.5x Healthcare median of 0.53%. Jim Chanos would check for overinvestment.

EBITDA Growth

21.31%

Increased from previous period

EBITDA change of 21.31% versus flat Healthcare. Walter Schloss would verify quality.

EBITDA Margin Growth

11.22%

Increased from previous period

Margin change of 11.22% versus flat Healthcare. Walter Schloss would verify quality.

Operating Income Growth

26.60%

Increased from previous period

Income change of 26.60% versus flat Healthcare. Walter Schloss would verify quality.

Operating Margin Growth

16.07%

Increased from previous period

Margin change of 16.07% versus flat Healthcare. Walter Schloss would verify quality.

Other Income/Expenses Growth

-1.33%

Increased from previous period

Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.

Pre-Tax Income Growth

24.06%

Increased from previous period

Income change of 24.06% versus flat Healthcare. Walter Schloss would verify quality.

Pre-Tax Margin Growth

13.74%

Increased from previous period

Margin change of 13.74% versus flat Healthcare. Walter Schloss would verify quality.

Income Tax Expense Growth

17.04%

Increased from previous period

Tax expense change of 17.04% versus flat Healthcare. Walter Schloss would verify strategy.

Net Income Growth

30.23%

Increased from previous period

Income change of 30.23% versus flat Healthcare. Walter Schloss would verify quality.

Net Margin Growth

19.40%

Increased from previous period

Margin change of 19.40% versus flat Healthcare. Walter Schloss would verify quality.

EPS Growth

30.16%

Increased from previous period

EPS change of 30.16% versus flat Healthcare. Walter Schloss would verify quality.

Diluted EPS Growth

30.16%

Increased from previous period

Diluted EPS change of 30.16% versus flat Healthcare. Walter Schloss would verify quality.

Share Count Growth (Basic)

-0.00%

Decreased from previous period

Share count reduction while Healthcare median is 0.00%. Seth Klarman would investigate strategy.

Share Count Growth (Diluted)

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric: